+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
[PRM130] Vaccine Efficacy, Effectiveness, Or Impact: Which One To Choose In Economic Evaluations Of Vaccines?
Home
Publications
[PRM130] Vaccine Efficacy, Effectiveness, Or Impact: Which One To Choose In Economic Evaluations Of Vaccines?
Back Home
[PRM130] Vaccine Efficacy, Effectiveness, Or Impact: Which One To Choose In Economic Evaluations Of Vaccines?
2017 ISPOR 20TH ANNUAL EUROPEAN CONGRESS
Standaert, B. | Dort, T. | Toumi, M. |
Volume: 20, Issue: 9, Pages: A754,
https://www.doi.org/10.1016/j.jval.2017.08.2115
The website uses cookies.
Learn More
Ok
